مقالات در نشریات
# | عنوان مقاله | نویسندگان | نشریه | تاریخ انتشار |
---|---|---|---|---|
۲۱ | Prognostic factors influencing prognosis in early breast cancer patients | Najafi, S., Sadeghi, M., Abasvandi, F., (...), Mohebi, K., Ghandchi, H. | Przeglad Menopauzalny | 2019 |
۲۲ | Factors impacting pathologic complete response after neoadjuvant chemotherapy in breast cancer: A single-center study | Olfatbakhsh, A., Tafazzoli-Harandi, H., Najafi, S., (...), Hesari, P.M., Hosseinpour, P. | International Journal of Cancer Management | 2018-5-1 |
۲۳ | The comparison of anthracyclinebased and non-anthracycline-based regimens in adjuvant chemotherapy of HER2-positive non-metastatic breast cancers | Najafi, S., Sadeghi, M., Shajari, M.R., Abasvandi, F., Mohebi, K. | Wspolczesna Onkologia | 2018 |
۲۴ | Clinicopathological features of non-metastatic triple negative breast cancer | Najafi, S., Mozaffari, H.R., Sadeghi, M. | Iranian Journal of Blood and Cancer, | 2017-3-1 |
۲۵ | Clinicopathology figures and survival of non-hodgkin's lymphoma in Iran | Najafi, S., Payandeh, M., Sadeghi, M. | International Journal of Cancer Management | 2017-1-1 |
۲۶ | Phase II study of adjuvant docetaxel and carboplatin with/without doxorubicin and cyclophosphamide in triple negative breast cancer: A randomised controlled clinical trial | Najafi, S., Payandeh, M., Sadeghi, M., (...), Shojaiyan, F., Abbasvandi, F. | Wspolczesna Onkologia, | 2017 |
۲۷ | Mapping catquest scores onto EQ-5D utility values in patients with cataract disease | Yousefi, M., Sheikhrobat, Y.B., Najafi, S., (...), Barouni, M., Biglu, M.-H. | Iranian Red Crescent Medical Journal, | 2017 |
۲۸ | Comparison of SF-6D and EQ-5D scores in patients with breast cancer | Yousefi, M., Najafi, S., Ghaffari, S., Mahboub-Ahari, A., Ghaderi, H. | Iranian Red Crescent Medical Journal | 2016-5-1 |
۲۹ | Phase III of study of R-CHOP-21 vs R-CHOP-14 for untreated stage III and IV B-cell non-Hodgkin's lymphoma: A report from Iran | Payandeh, M., Najafi, S., Shojaiyan, F.-Z., Sadeghi, M. | Asian Pacific Journal of Cancer Prevention, | 2016-4-19 |
۳۰ | Mapping catquest scores onto EQ-5D utility values in patients with cataract disease | Yousefi, M., Sheikhrobat, Y.B., Najafi, S., (...), Barouni, M., Biglu, M.-H. | Iranian Red Crescent Medical Journal, | 2016-3-1 |
۳۱ | Effect of ginger and chamomile on nausea and vomiting caused by chemotherapy in Iranian women with breast cancer | Sanaati, F., Najafi, S., Kashaninia, Z., Sadeghi, M. | Asian Pacific Journal of Cancer Prevention, | 2016 |
۳۲ | Transcatheter arterial chemoembolization therapy for patients with unresectable hepatocellular carcinoma | Firouznia, K., Ghanaati, H., Alavian, S.M., (...), Shakiba, M., Jalali, A.H. | Hepatitis Monthly, | 2014-12-28 |
۳۳ | Taxane-based regimens as a risk factor for chemotherapy-induced amenorrhea | Najafi, S., Esmaeeli Djavid, G., Mehrdad, N., (...), Bahrami, A., Heidari, K. | Menopause | 2011-2-1 |
۳۴ | Gluten sensitive enteropathy in patients with iron deficiency anemia of unknown origin | Zamani, F., Mohamadnejad, M., Shakeri, R., (...), Ghavamzadeh, A., Malekzadeh, R. | World Journal of Gastroenterology, | 2008-12-28 |
۳۵ | Diagnostic relevance of interleukin-6 and tumor necrosis factor alpha in discriminating high risk and low risk groups in febrile patiens with neutropenia | Parsa, M., Najafi, S.N., Jonaidi Jafari, N., (...), Radfar, M.H., Ghofrani, H. | Journal of Biological Sciences | 2007-2-15 |
۳۶ | TGF-b and TGF-bRII fluctuant in HLA-DR negative AML patients | Mohammadi, M.H., Amirizadeh, N., Farsani, M.A., (...), Najafi, S., Azarkeivan, A. | Genetics in the Third Millennium, | (2016-12-1) |
نمایش ۲۱ تا ۳۶ مورد از کل ۳۶ مورد.